Welcome to our dedicated page for AUNA S.A. SEC filings (Ticker: AUNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Auna S.A.'s SEC filings document a foreign private issuer operating a healthcare services and health-plan platform in Mexico, Peru and Colombia. Current reports on Form 6-K furnish press releases, IFRS financial statements, operating KPIs, annual Form 20-F availability, and updates on healthcare services in Peru, Colombia and Mexico and Oncosalud Peru.
The filing record also covers capital-structure matters, including senior secured notes and completed debt refinancing, as well as material project and agreement disclosures related to the Torre Trecca public-private partnership. These documents frame Auna's results, leverage, segment activity and corporate reporting obligations under its NYSE-listed issuer structure.
Auna S.A. reported preliminary key performance indicators for the second quarter ended June 30, 2026 across its healthcare operations in Mexico, Peru and Colombia. Metrics include emergency treatments, surgeries, days hospitalized, chemotherapies and radiotherapies, plan memberships and protected lives under risk-sharing agreements.
In 2Q 2026, Healthcare Services Peru recorded 51,769 emergency treatments and capacity utilization of 80.2%, while Healthcare Services Colombia reported 3,143,694 protected lives and capacity utilization of 79.2%. As of June 30, 2026, Auna operated 31 facilities with 2,337 beds and 1.4 million health plan members. These indicators are preliminary and subject to revision.
RWC Asset Management LLP reported beneficial ownership of 1,520,929 shares of AUNA, S.A., representing 5.05% of the class as of 06/30/2026. The filing is an amended Schedule 13G/A (Amendment No. 8) and shows RWC holds sole voting and dispositive power over the reported shares.
Auna S.A. reported the results of its annual general meeting, where shareholders approved all matters presented to them. The company also updated its board structure, setting the board at seven members after Jorge Basadre and Guadalupe Phillips stepped down, with the vacancies not being filled for now. Following these changes, the board still has a majority of independent directors. As of March 31, 2026, Auna’s Latin American healthcare platform included 31 facilities with 2,337 beds and 1.4 million health plan members.
AUNA S.A.’s president and director Jesus Zamora León reported open-market purchases of 51,454 Class A Common Shares between May 20 and May 29, 2026, at prices between $4.15 and $4.39 per share.
Following these transactions, he holds 69,130 Class A shares directly and 55,134 Class A shares indirectly through Enfoca Ltd. He is also indirectly associated with 32,029,016 Class B common shares held by the Enfoca Entities, each convertible into one Class A share under the issuer’s articles. The filing notes it was inadvertently filed late due to an administrative error.
AUNA S.A. director Wilton John sold 17,574 Class A Common Shares in an open-market transaction. The weighted average sale price was $4.1711 per share, with individual trades between $4.1700 and $4.2001. Following the sale, he directly owns 49,974 Class A Common Shares.
AUNA S.A. director and president Zamora Leon Jesus filed an amended Form 3 showing his existing ownership, not new trades. He indirectly holds 32,029,016 Class B common shares through Enfoca entities and indirectly holds 10,100 Class A common shares through Enfoca Ltd.
He also directly owns 30,710 Class A common shares. In addition, he holds share options over 209,677 Class A common shares at an exercise price of $6.32, plus performance share options over 277,778 shares at $6.32 and 2,217,528 shares at $12.00, all with long-dated expirations and vesting tied to future share-price and time-based conditions.
AUNA S.A. ownership filing: Daniel Kaufman reports beneficial ownership of 1,827,749 Class A Ordinary Shares, representing 6.1% of the class.
The filing cites 30,138,747 Class A Ordinary Shares outstanding as of April 9, 2026 from the issuer's 20-F. Kaufman reports sole voting and dispositive power over the shares.
AUNA S.A. President and director Zamora Leon Jesus bought Class A Common Shares in open-market transactions. He purchased 8,727 Class A shares on May 26, 2026 at a weighted average price of $4.2389 per share and 23,273 Class A shares on May 27, 2026 at a weighted average price of $4.1981 per share, totaling 32,000 shares. After these purchases, he directly owns 62,710 Class A shares.
He is also reported as indirectly owning 32,029,016 Class B common shares through the Enfoca Entities. Each Class B common share is convertible into one Class A common share. The reported prices reflect multiple trades within ranges from $4.17 to $4.24 per share.
Auna S.A. is calling its 2026 Annual General Meeting of shareholders in Luxembourg on June 30, 2026 at 3:00 p.m. CEST. Shareholders are asked to approve 2025 standalone and consolidated financial statements, related audit reports, and the allocation of the 2025 financial result.
The agenda also covers confirming share awards to independent directors, granting discharge to directors and the statutory auditor for the 2025 financial year, reappointing the statutory auditor for 2026, and ratifying director remuneration and certain compensations. Shareholders of record as of May 15, 2026 can vote in person, online, or by proxy, with the board recommending a vote “FOR” all nine proposals.